With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Hosted on MSN8d
Miltenyi Biotec's ZAMTO Cell, claimed to be India's first dual-target CAR-T cancer therapy, expected by 2026German biotechnology company Miltenyi Biotec has said that its CAR-T therapy, ZAMTO Cell, for B-cell lymphoma, is expected to ...
One of the biggest hurdles in the sugar and ethanol industries is strict government regulations on wastewater management, ...
Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...
Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation.
The first-of-its-kind facility in India has received an investment of $75 million from the company to build it vertically ...
Early and mid-stage biotech companies in 2025 face a significantly ... For instance, clinical trials in India can cost 50% less than in the U.S. Maintaining data integrity and regulatory ...
Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback